home / stock / nxtc / nxtc message board
Subject | By | Source | When |
---|---|---|---|
NextCure Presented NC410 Data at the Extracellular Matrix | conix | investorshub | 06/27/2022 3:36:36 PM |
* * $NXTC Video Chart 11-05-2019 * * | ClayTrader | investorshub | 11/05/2019 10:15:30 PM |
Buying 78... stop 64 | europtiger | investorshub | 11/05/2019 7:05:21 PM |
Short | stock1ace1 | investorshub | 11/05/2019 5:40:36 PM |
These can be tricky when they keep halting | PennyDad | investorshub | 11/05/2019 5:07:38 PM |
Insane gains here. | rocco_p_coletrain | investorshub | 11/05/2019 5:05:13 PM |
News, Short Squeeze, Breakout and More Instantly...
NextCure Inc. Company Name:
NXTC Stock Symbol:
NYSE Market:
Of the evaluable ICI-naïve MSS/MSI-L CRC patients without liver metastasis, there were 2 confirmed ongoing PRs and a disease control rate of 51%...
Of the evaluable ICI-naïve MSS/MSI-L CRC patients without liver metastasis, there were 2 confirmed ongoing PRs and a disease control rate of 51% Of the 7 evaluable ovarian cancer patients, there were 3 PRs and a disease control rate of 43% Data to be presented June 1, 2024,...
Phase 1b data for NC410 combo with pembro to be presented at ASCO annual meeting on June 1 Presented preclinical data from LNCB74 (B7-H4 ADC) at recent AACR annual meeting Cash of approximately $96.0 million expected to fund operations into second half of 2026 BELTSVILLE...